endpoints.news is our new home on June 1. endpts.com will still work, but the front door is now https://endpoints.news

Startups channel feed

Nu­va­tion inks all-stock deal for US-Chi­na on­col­o­gy biotech An­Heart

Last year
Deals
China

No­vo to buy mid-stage heart fail­ure biotech Car­dior for up to $1.1B

Last year
Deals
Pharma

Bound­less Bio seeks $88M in IPO as it runs two Ph1 can­cer tri­als

Last year
Financing

For­mer Prometheus ex­ecs raise $400M for pre­ci­sion im­munol­o­gy start­up: 'The band is back to­geth­er'

Last year
Financing

Ex­clu­sive: ‘If you could hal­lu­ci­nate a pro­tein’: Proflu­ent snags $35M for gen­er­a­tive AI mod­els

Last year
Financing
AI

The megaround re­bound: Pri­vate biotechs rack up $100M+ fi­nanc­ings

Last year
Financing

Clasp Ther­a­peu­tics emerges with $150M based on work from Bert Vo­gel­stein, Drew Par­doll

Last year
Financing

'Cell ther­a­py with­out cell­s': Cap­stan rais­es $175M to test in vi­vo CAR-T

Last year
Financing
Cell/Gene Tx

Mid-stage neu­ro­science start­up En­grail rais­es $157M

Last year
Financing

Con­tineum Ther­a­peu­tics files for IPO with MS drug in PhII

Last year
Financing

It takes GUTS to be BOLD: A look at the new biotech tick­ers

Last year

Pfiz­er-backed UK biotech rais­es £25M to ad­vance mi­tophagy pipeline

Last year
Financing

Ger­man ADC biotech Tubu­lis rais­es $138M to en­ter the clin­ic and ex­pand in US

Last year
Financing

Swedish biotech rais­es €30M Se­ries A to de­vel­op off-the-shelf gene ther­a­py for sol­id tu­mors

Last year
Financing
Cell/Gene Tx

Ex­clu­sive: ‘Chat­G­PT for DNA’: Re­la­tion nabs $35M, with Nvidia back­ing, for os­teo­poro­sis work

Last year
Financing
AI

Mer­ck pens pact with Pearl Bio for new bi­o­log­ics in can­cer

Last year
Deals
Pharma

Ear­ly-stage on­col­o­gy start­up Bound­less Bio files for IPO

Last year
Financing

As the biotech mar­kets warm up, signs point to crossover rounds re­turn­ing

Last year
Financing

Sion­na rais­es $182M for cys­tic fi­bro­sis drugs dif­fer­ent from Ver­tex's ap­proach

Last year
Financing

Ex­clu­sive: No­cion rais­es $62M for dif­fer­ent ap­proach to chron­ic cough than Mer­ck, GSK

Last year
Financing

Ar­rakis Ther­a­peu­tics re­duces head­count by 20%

Last year
People

Fog­Phar­ma bags $145M, adds Alex­is Borisy to the board 

Last year
Financing

'Sweet spot' of CNS cell ther­a­py: Ke­nai emerges with $82M for Parkin­son's study

Last year
Financing
Cell/Gene Tx

Blos­somHill rais­es $100M in bid to re­peat founder­s' can­cer suc­cess at Turn­ing Point

Last year
Financing
First page Previous page 18192021222324 Next page Last page
A service from the Financial Times